FIA
OLMA icon

FNY Investment Advisers’s Olema Pharmaceuticals OLMA Stock Holding History

FNY Investment Advisers’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,707
Closed -$16K – 1323
2025
Q3 		$16K Sell
1,707
-8,293
-83% -$49.8K 0.01% 721
2025
Q2 		$42K Buy
10,000
+5,000
+100% +$22.3K 0.02% 435
2025
Q1 		$18K Buy
+5,000
New +$25.1K 0.01% 420

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

FNY Investment Advisers's OLMA Position: Q4 2025 in Review

FNY Investment Advisers sold out of Olema Pharmaceuticals (OLMA) in Q4 2025, closing a stake of 1,707 shares — an estimated $16K sold.

FNY Investment Advisers first reported a position in OLMA in Q1 2025 and held it in 3 quarters. The position peaked at $42K in Q2 2025. 200 funds tracked by Wall St. Rank hold OLMA as of Q4 2025.

  • FNY Investment Advisers reported no remaining Olema Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 1,707 Olema Pharmaceuticals shares in Q4 2025, an estimated $16K.
  • FNY Investment Advisers first reported a position in Olema Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • FNY Investment Advisers's Olema Pharmaceuticals position peaked at $42K in Q2 2025.
  • 200 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.